Francesca Blasco

Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation

Pascal Furet, Vito Guagnano, Robin A. Fairhurst et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 460 citations · Full text

Medicine, Receptor Tyrosine Kinase, Immunology +7

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis

Ujjini H. Manjunatha, Sumiti Vinayak, Jennifer A. Zambriski et al. · Nature · 2017 · 191 citations · Full text

Pharmacology, Medicine, Pathology +1

Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis

Srinivasa P. S. Rao, Suresh B. Lakshminarayana, Ravinder Reddy Kondreddi et al. · Science Translational Medicine · 2013 · 149 citations

Tuberculosis Prevention, Pharmacotherapy, Antimicrobial Chemotherapy +18

Direct inhibitors of InhA are active against <i>Mycobacterium tuberculosis</i>

Ujjini H. Manjunatha, Srinivasa P. S. Rao, Ravinder Reddy Kondreddi et al. · Science Translational Medicine · 2015 · 129 citations · Full text

Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805

Fabienne Baffert, Catherine H. Régnier, Alain De Pover et al. · Molecular Cancer Therapeutics · 2010 · 119 citations

Pharmacotherapy, Excellent Selectivity, Pharmaceutical Chemistry +20